The Current Landscape of Genetic Testing in Cardiovascular Malformations: Opportunities and Challenges

Frontiers in Cardiovascular Medicine

Volumn 3, Issue , 2016, Pages

  Landis, Benjamin J ^a   Ware, Stephanie M ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

congenital heart disease; genetics; genomics; mutation; next generation sequencing; phenomics; phenotyping

Indexed keywords

EID: 85015449159     PISSN: None     EISSN: 2297055X     Source Type: Journal    
DOI: 10.3389/fcvm.2016.00022     Document Type: Review

References (91)

1. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol (2002) 39(12):1890–900.10.1016/S0735-1097(02)01886-712084585
2. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al. Heart disease and stroke statistics – 2011 update: a report from the American Heart Association. Circulation (2011) 123(4):e18–209.10.1161/CIR.0b013e3182009701
3. Centers for Disease Control and Prevention (CDC). Hospital stays, hospital charges, and in-hospital deaths among infants with selected birth defects – United States, 2003. MMWR Morb Mortal Wkly Rep (2007) 56(2):25–9.17230142
4. Boneva RS, Botto LD, Moore CA, Yang Q, Correa A, Erickson JD. Mortality associated with congenital heart defects in the United States: trends and racial disparities, 1979-1997. Circulation (2001) 103(19):2376–81.10.1161/01.CIR.103.19.237611352887
5. Hoffman JI. Incidence of congenital heart disease: II. Prenatal incidence. Pediatr Cardiol (1995) 16(4):155–65.10.1007/BF008019077567659
6. Lander J, Ware SM. Copy number variation in congenital heart defects. Curr Genet Med Rep (2014) 2(3):168–78.10.1007/s40142-014-0049-3
7. Pierpont ME, Basson CT, Benson DW, Jr Gelb BD, Giglia TM, Goldmuntz E, et al. Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation (2007) 115(23):3015–38.10.1161/CIRCULATIONAHA.106.18305617519398
8. Landis BJ, Cooper DS, Hinton RB. CHD associated with syndromic diagnoses: peri-operative risk factors and early outcomes. Cardiol Young (2016) 26(1):30–52.10.1017/S104795111500138926345374
9. Cowan JR, Ware SM. Genetics and genetic testing in congenital heart disease. Clin Perinatol (2015) 42(2):373–93,ix.10.1016/j.clp.2015.02.009
10. Robinson PN. Deep phenotyping for precision medicine. Hum Mutat (2012) 33(5):777–80.10.1002/humu.2208022504886
11. Ferencz C, Loffredo CA, Corea-Villasenor A, Wilson PD. Genetic and Environmental Risk Factors for Major Cardiovascular Malformations: The Baltimore-Washington Infant Study 1981-1989. Armonk, NY: Futura Publishing Co., Inc (1997). 463 p.
12. Oyen N, Poulsen G, Boyd HA, Wohlfahrt J, Jensen PK, Melbye M. Recurrence of congenital heart defects in families. Circulation (2009) 120(4):295–301.10.1161/CIRCULATIONAHA.109.85798719597048
13. Cripe L, Andelfinger G, Martin LJ, Shooner K, Benson DW. Bicuspid aortic valve is heritable. J Am Coll Cardiol (2004) 44(1):138–43.10.1016/j.jacc.2004.03.05015234422
14. McBride KL, Pignatelli R, Lewin M, Ho T, Fernbach S, Menesses A, et al. Inheritance analysis of congenital left ventricular outflow tract obstruction malformations: segregation, multiplex relative risk, and heritability. Am J Med Genet A (2005) 134a(2):180–6.10.1002/ajmg.a.3060215690347
15. Hinton RB, Jr Martin LJ, Tabangin ME, Mazwi ML, Cripe LH, Benson DW. Hypoplastic left heart syndrome is heritable. J Am Coll Cardiol (2007) 50(16):1590–5.10.1016/j.jacc.2007.07.02117936159
16. Oyen N, Poulsen G, Wohlfahrt J, Boyd HA, Jensen PK, Melbye M. Recurrence of discordant congenital heart defects in families. Circ Cardiovasc Genet (2010) 3(2):122–8.10.1161/CIRCGENETICS.109.89010320173214
17. Burn J, Brennan P, Little J, Holloway S, Coffey R, Somerville J, et al. Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet (1998) 351(9099):311–6.10.1016/S0140-6736(97)06486-69652610
18. Gill HK, Splitt M, Sharland GK, Simpson JM. Patterns of recurrence of congenital heart disease: an analysis of 6,640 consecutive pregnancies evaluated by detailed fetal echocardiography. J Am Coll Cardiol (2003) 42(5):923–9.10.1016/S0735-1097(03)00853-212957444
19. Canfield MA, Honein MA, Yuskiv N, Xing J, Mai CT, Collins JS, et al. National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999-2001. Birth Defects Res A Clin Mol Teratol (2006) 76(11):747–56.10.1002/bdra.2029417051527
20. Pradat P, Francannet C, Harris JA, Robert E. The epidemiology of cardiovascular defects, part I: a study based on data from three large registries of congenital malformations. Pediatr Cardiol (2003) 24(3):195–221.10.1007/s00246-002-9401-612632215
21. Becker S, Al Halees Z. First-cousin matings and congenital heart disease in Saudi Arabia. Community Genet (1999) 2(2–3):69–73.15181336
22. Becker SM, Al Halees Z, Molina C, Paterson RM. Consanguinity and congenital heart disease in Saudi Arabia. Am J Med Genet (2001) 99(1):8–13.10.1002/1096-8628(20010215)99:1<8::AID-AJMG1116>3.0.CO;2-U11170087
23. Chehab G, Chedid P, Saliba Z, Bouvagnet P. Congenital cardiac disease and inbreeding: specific defects escape higher risk due to parental consanguinity. Cardiol Young (2007) 17(4):414–22.10.1017/S104795110700070417594737
24. Nabulsi MM, Tamim H, Sabbagh M, Obeid MY, Yunis KA, Bitar FF. Parental consanguinity and congenital heart malformations in a developing country. Am J Med Genet A (2003) 116a(4):342–7.10.1002/ajmg.a.1002012522788
25. Ramegowda S, Ramachandra NB. Parental consanguinity increases congenital heart diseases in South India. Ann Hum Biol (2006) 33(5–6):519–28.10.1080/0301446060090934917381050
26. Griffin HR, Topf A, Glen E, Zweier C, Stuart AG, Parsons J, et al. Systematic survey of variants in TBX1 in non-syndromic tetralogy of Fallot identifies a novel 57 base pair deletion that reduces transcriptional activity but finds no evidence for association with common variants. Heart (2010) 96(20):1651–5.10.1136/hrt.2010.20012120937753
27. Merla G, Brunetti-Pierri N, Piccolo P, Micale L, Loviglio MN. Supravalvular aortic stenosis: elastin arteriopathy. Circ Cardiovasc Genet (2012) 5(6):692–6.10.1161/CIRCGENETICS.112.96286023250899
28. Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet (2010) 86(5):749–64.10.1016/j.ajhg.2010.04.00620466091
29. Regier DA, Friedman JM, Marra CA. Value for money? Array genomic hybridization for diagnostic testing for genetic causes of intellectual disability. Am J Hum Genet (2010) 86(5):765–72.10.1016/j.ajhg.2010.03.00920398885
30. Greenway SC, Pereira AC, Lin JC, DePalma SR, Israel SJ, Mesquita SM, et al. De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot. Nat Genet (2009) 41(8):931–5.10.1038/ng.41519597493
31. Ferencz C, Boughman JA, Neill CA, Brenner JI, Perry LW. Congenital cardiovascular malformations: questions on inheritance. Baltimore-Washington Infant Study Group. J Am Coll Cardiol (1989) 14(3):756–63.10.1016/0735-1097(89)90122-82768723
32. Grech V, Gatt M. Syndromes and malformations associated with congenital heart disease in a population-based study. Int J Cardiol (1999) 68(2):151–6.10.1016/S0167-5273(98)00354-410189002
33. Meberg A, Hals J, Thaulow E. Congenital heart defects – chromosomal anomalies, syndromes and extracardiac malformations. Acta Paediatr (2007) 96(8):1142–5.10.1111/j.1651-2227.2007.00381.x
34. Zaidi S, Choi M, Wakimoto H, Ma L, Jiang J, Overton JD, et al. De novo mutations in histone-modifying genes in congenital heart disease. Nature (2013) 498(7453):220–3.10.1038/nature1214123665959
35. Homsy J, Zaidi S, Shen Y, Ware JS, Samocha KE, Karczewski KJ, et al. De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies. Science (2015) 350(6265):1262–6.10.1126/science.aac939626785492
36. Lage K, Mollgard K, Greenway S, Wakimoto H, Gorham JM, Workman CT, et al. Dissecting spatio-temporal protein networks driving human heart development and related disorders. Mol Syst Biol (2010) 6:381.10.1038/msb.2010.3620571530
37. Lage K, Greenway SC, Rosenfeld JA, Wakimoto H, Gorham JM, Segre AV, et al. Genetic and environmental risk factors in congenital heart disease functionally converge in protein networks driving heart development. Proc Natl Acad Sci U S A (2012) 109(35):14035–40.10.1073/pnas.121073010922904188
38. Rana MS, Christoffels VM, Moorman AF. A molecular and genetic outline of cardiac morphogenesis. Acta Physiol (Oxf) (2013) 207(4):588–615.10.1111/apha.1206123297764
39. Kathiriya IS, Nora EP, Bruneau BG. Investigating the transcriptional control of cardiovascular development. Circ Res (2015) 116(4):700–14.10.1161/CIRCRESAHA.116.30283225677518
40. Breckpot J, Thienpont B, Peeters H, de Ravel T, Singer A, Rayyan M, et al. Array comparative genomic hybridization as a diagnostic tool for syndromic heart defects. J Pediatr (2010) 156(5):810–7, 7.e1–7.e4.10.1016/j.jpeds.2009.11.04920138633
41. Breckpot J, Thienpont B, Arens Y, Tranchevent LC, Vermeesch JR, Moreau Y, et al. Challenges of interpreting copy number variation in syndromic and non-syndromic congenital heart defects. Cytogenet Genome Res (2011) 135(3–4):251–9.10.1159/00033127221921585
42. Thienpont B, Mertens L, de Ravel T, Eyskens B, Boshoff D, Maas N, et al. Submicroscopic chromosomal imbalances detected by array-CGH are a frequent cause of congenital heart defects in selected patients. Eur Heart J (2007) 28(22):2778–84.10.1093/eurheartj/ehl56017384091
43. Richards AA, Santos LJ, Nichols HA, Crider BP, Elder FF, Hauser NS, et al. Cryptic chromosomal abnormalities identified in children with congenital heart disease. Pediatr Res (2008) 64(4):358–63.10.1203/PDR.0b013e31818095d018535492
44. Lalani SR, Shaw C, Wang X, Patel A, Patterson LW, Kolodziejska K, et al. Rare DNA copy number variants in cardiovascular malformations with extracardiac abnormalities. Eur J Hum Genet (2013) 21(2):173–81.10.1038/ejhg.2012.15522929023
45. Baker K, Sanchez-de-Toledo J, Munoz R, Orr R, Kiray S, Shiderly D, et al. Critical congenital heart disease – utility of routine screening for chromosomal and other extracardiac malformations. Congenit Heart Dis (2012) 7(2):145–50.10.1111/j.1747-0803.2011.00585.x
46. Connor JA, Hinton RB, Miller EM, Sund KL, Ruschman JG, Ware SM. Genetic testing practices in infants with congenital heart disease. Congenit Heart Dis (2014) 9(2):158–67.10.1111/chd.1211223782710
47. Blue GM, Kirk EP, Giannoulatou E, Dunwoodie SL, Ho JW, Hilton DC, et al. Targeted next-generation sequencing identifies pathogenic variants in familial congenital heart disease. J Am Coll Cardiol (2014) 64(23):2498–506.10.1016/j.jacc.2014.09.04825500235
48. Jia Y, Louw JJ, Breckpot J, Callewaert B, Barrea C, Sznajer Y, et al. The diagnostic value of next generation sequencing in familial nonsyndromic congenital heart defects. Am J Med Genet A (2015) 167(8):1822–9.10.1002/ajmg.a.3710825931334
49. Bonachea EM, Zender G, White P, Corsmeier D, Newsom D, Fitzgerald-Butt S, et al. Use of a targeted, combinatorial next-generation sequencing approach for the study of bicuspid aortic valve. BMC Med Genomics (2014) 7:56.10.1186/1755-8794-7-5625260786
50. Arrington CB, Bleyl SB, Matsunami N, Bonnell GD, Otterud BE, Nielsen DC, et al. Exome analysis of a family with pleiotropic congenital heart disease. Circ Cardiovasc Genet (2012) 5(2):175–82.10.1161/CIRCGENETICS.111.96179722337856
51. Brookes AJ, Robinson PN. Human genotype-phenotype databases: aims, challenges and opportunities. Nat Rev Genet (2015) 16(12):702–15.10.1038/nrg393226553330
52. Freimer N, Sabatti C. The human phenome project. Nat Genet (2003) 34(1):15–21.10.1038/ng0503-15
53. Lanktree MB, Hassell RG, Lahiry P, Hegele RA. Phenomics: expanding the role of clinical evaluation in genomic studies. J Investig Med (2010) 58(5):700–6.10.231/JIM.0b013e3181d844f720216460
54. Robinson PN, Kohler S, Bauer S, Seelow D, Horn D, Mundlos S. The human phenotype ontology: a tool for annotating and analyzing human hereditary disease. Am J Hum Genet (2008) 83(5):610–5.10.1016/j.ajhg.2008.09.01718950739
55. Gene Ontology Consortium. Creating the gene ontology resource: design and implementation. Genome Res (2001) 11(8):1425–33.10.1101/gr.18080111483584
56. Schriml LM, Arze C, Nadendla S, Chang YW, Mazaitis M, Felix V, et al. Disease ontology: a backbone for disease semantic integration. Nucleic Acids Res (2012) 40(Database issue):D940–6.10.1093/nar/gkr97222080554
57. Smith CL, Eppig JT. The Mammalian Phenotype Ontology as a unifying standard for experimental and high-throughput phenotyping data. Mamm Genome (2012) 23(9–10):653–68.10.1007/s00335-012-9421-322961259
58. Kohler S, Doelken SC, Mungall CJ, Bauer S, Firth HV, Bailleul-Forestier I, et al. The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Res (2014) 42(Database issue):D966–74.10.1093/nar/gkt102624217912
59. Riggs ER, Jackson L, Miller DT, Van Vooren S. Phenotypic information in genomic variant databases enhances clinical care and research: the International Standards for Cytogenomic Arrays Consortium experience. Hum Mutat (2012) 33(5):787–96.10.1002/humu.2205222331816
60. Rehm HL, Berg JS, Brooks LD, Bustamante CD, Evans JP, Landrum MJ, et al. ClinGen – the Clinical Genome Resource. N Engl J Med (2015) 372(23):2235–42.10.1056/NEJMsr1406261
61. Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res (2014) 42(Database issue):D980–5.10.1093/nar/gkt111324234437
62. Firth HV, Richards SM, Bevan AP, Clayton S, Corpas M, Rajan D, et al. DECIPHER: database of chromosomal imbalance and phenotype in humans using Ensembl resources. Am J Hum Genet (2009) 84(4):524–33.10.1016/j.ajhg.2009.03.01019344873
63. Buske OJ, Girdea M, Dumitriu S, Gallinger B, Hartley T, Trang H, et al. PhenomeCentral: a portal for phenotypic and genotypic matchmaking of patients with rare genetic diseases. Hum Mutat (2015) 36(10):931–40.10.1002/humu.2285126251998
64. Girdea M, Dumitriu S, Fiume M, Bowdin S, Boycott KM, Chenier S, et al. PhenoTips: patient phenotyping software for clinical and research use. Hum Mutat (2013) 34(8):1057–65.10.1002/humu.2234723636887
65. Abbott ME. Atlas of Congenital Cardiac Disesae. New York: The American Heart Association (1936).
66. Franklin RC, Jacobs JP, Krogmann ON, Beland MJ, Aiello VD, Colan SD, et al. Nomenclature for congenital and paediatric cardiac disease: historical perspectives and The International Pediatric and Congenital Cardiac Code. Cardiol Young (2008) 18(Suppl 2):70–80.10.1017/S104795110800279519063777
67. Newburger JW, Fyler J, Colan SD. Donald Charles Fyler: 1924-2011. Cardiol Young (2011) 21(5):485–9.10.1017/S1047951111001089
68. Mavroudis C, Bove EL, Cameron DE, Drinkwater DC, Jr Edwards FH, Hammon JW, Jr et al. The Society of Thoracic Surgeons’ National Congenital Heart Surgery Database. Ann Thorac Surg (1995) 59(2):554–6.10.1016/0003-4975(94)00947-6
69. Botto LD, Lin AE, Riehle-Colarusso T, Malik S, Correa A, National Birth Defects Prevention Study. Seeking causes: classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res A Clin Mol Teratol (2007) 79(10):714–27.10.1002/bdra.2040317729292
70. Khoury MJ, Moore CA, James LM, Cordero JF. The interaction between dysmorphology and epidemiology: methodologic issues of lumping and splitting. Teratology (1992) 45(2):133–8.10.1002/tera.1420450206
71. Spicer DE, Hsu HH, Co-Vu J, Anderson RH, Fricker FJ. Ventricular septal defect. Orphanet J Rare Dis (2014) 9:144.10.1186/s13023-014-0144-225523232
72. Gelehrter S, Ensing G. Ventricular septal defects. In: Eidem BW, editor. Echocardiography in Pediatric and Adult Congenital Heart Disease. Philadelphia, PA: Lippincott Williams & Wilkins (2010). p. 158–75.
73. Collett RW, Edwards JE. Persistent truncus arteriosus; a classification according to anatomic types. Surg Clin North Am (1949) 29(4):1245–70.
74. Van Praagh R. Truncus arteriosus: what is it really and how should it be classified? Eur J Cardiothorac Surg (1987) 1(2):65–70.10.1016/1010-7940(87)90014-5
75. Lai WW, Geva T, Shirali GS, Frommelt PC, Humes RA, Brook MM, et al. Guidelines and standards for performance of a pediatric echocardiogram: a report from the Task Force of the Pediatric Council of the American Society of Echocardiography. J Am Soc Echocardiogr (2006) 19(12):1413–30.10.1016/j.echo.2006.09.001
76. Lopez L, Colan SD, Frommelt PC, Ensing GJ, Kendall K, Younoszai AK, et al. Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council. J Am Soc Echocardiogr (2010) 23(5):465–95; quiz 576–7.10.1016/j.echo.2010.03.019
77. Cantinotti M, Scalese M, Molinaro S, Murzi B, Passino C. Limitations of current echocardiographic nomograms for left ventricular, valvular, and arterial dimensions in children: a critical review. J Am Soc Echocardiogr (2012) 25(2):142–52.10.1016/j.echo.2011.10.01622101087
78. Zemojtel T, Kohler S, Mackenroth L, Jager M, Hecht J, Krawitz P, et al. Effective diagnosis of genetic disease by computational phenotype analysis of the disease-associated genome. Sci Transl Med (2014) 6(252):252ra123.10.1126/scitranslmed.300926225186178
79. Masino AJ, Dechene ET, Dulik MC, Wilkens A, Spinner NB, Krantz ID, et al. Clinical phenotype-based gene prioritization: an initial study using semantic similarity and the human phenotype ontology. BMC Bioinformatics (2014) 15:248.10.1186/1471-2105-15-24825047600
80. Smedley D, Robinson PN. Phenotype-driven strategies for exome prioritization of human Mendelian disease genes. Genome Med (2015) 7(1):81.10.1186/s13073-015-0199-226229552
81. Singleton MV, Guthery SL, Voelkerding KV, Chen K, Kennedy B, Margraf RL, et al. Phevor combines multiple biomedical ontologies for accurate identification of disease-causing alleles in single individuals and small nuclear families. Am J Hum Genet (2014) 94(4):599–610.10.1016/j.ajhg.2014.03.01024702956
82. Javed A, Agrawal S, Ng PC. Phen-Gen: combining phenotype and genotype to analyze rare disorders. Nat Methods (2014) 11(9):935–7.10.1038/nmeth.304625086502
83. Robinson PN, Kohler S, Oellrich A, Wang K, Mungall CJ, Lewis SE, et al. Improved exome prioritization of disease genes through cross-species phenotype comparison. Genome Res (2014) 24(2):340–8.10.1101/gr.160325.11324162188
84. Kaltman JR, Schramm C, Pearson GD. The National Heart, Lung, and Blood Institute Bench to Bassinet Program: a new paradigm for translational research. J Am Coll Cardiol (2010) 55(12):1262–5.10.1016/j.jacc.2009.11.055
85. Gelb B, Brueckner M, Chung W, Goldmuntz E, Kaltman J, Kaski JP, et al. The Congenital Heart Disease Genetic Network Study: rationale, design, and early results. Circ Res (2013) 112(4):698–706.10.1161/CIRCRESAHA.111.30029723410879
86. Li Y, Klena NT, Gabriel GC, Liu X, Kim AJ, Lemke K, et al. Global genetic analysis in mice unveils central role for cilia in congenital heart disease. Nature (2015) 521(7553):520–4.10.1038/nature1426925807483
87. Fahed AC, Gelb BD, Seidman JG, Seidman CE. Genetics of congenital heart disease: the glass half empty. Circ Res (2013) 112(4):707–20.10.1161/CIRCRESAHA.112.30085323410880
88. Strickland MJ, Riehle-Colarusso TJ, Jacobs JP, Reller MD, Mahle WT, Botto LD, et al. The importance of nomenclature for congenital cardiac disease: implications for research and evaluation. Cardiol Young (2008) 18(Suppl 2):92–100.10.1017/S104795110800251519063779
89. Chen W, Xia X, Huang Y, Chen X, Han JJ. Bioimaging for quantitative phenotype analysis. Methods (2016) 102:20–25.10.1016/j.ymeth.2016.01.017
90. Ingles J, Semsarian C. Conveying a probabilistic genetic test result to families with an inherited heart disease. Heart Rhythm (2014) 11(6):1073–8.10.1016/j.hrthm.2014.03.01724632221
91. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med (2015) 17(5):405–24.10.1038/gim.2015.3025741868